Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression
Completed
Conditions studied: Treatment Resistant Depression
In brief
Study TRD subjects' resistance to at least 2 different antidepressants, we hypothesize that because of their significant depression and treatment resistant status they are most likely to exhibit BSMN pathway abnormalities.
Key facts
- Study ID
- NCT03109717
- Run by
- Kathryn O'Connor
- People needed
- 11
- Starts
- 2016-07-01
- Expected to finish
- 2021-05-01
- Last updated by the study team
- 2021-06-18
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
Where it is running
- Cleveland Clinic — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.